GlassScriptPhysician profile
Jay Michael Truitt
NPI 1659868909
$3,375.79
in general payments reported to CMS, 2019-2025
22 companies · $619 in 2025
The $619 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $283 · 2021: $1,033 · 2022: $795 · 2023: $520 · 2024: $20.00 · 2025: $619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,044 · Education: $94.99 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.02 |
| Education | $94.99 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,293.52 | 2020-2025 | Skyrizi, Rinvoq |
| Regeneron Healthcare Solutions, INC. | $596.40 | 2021-2025 | Dupixent |
| Amgen INC. | $331.45 | 2021-2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $169.79 | 2021-2023 | Ilumya, Odomzo, Blu-U |
| Arcutis Biotherapeutics, INC. | $159.93 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $137.92 | 2025 | Tremfya, Stelara, Simponi |
| Celgene Corporation | $106.62 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.61 | 2025 | Cabtreo, Arazlo, Siliq |
| Lilly USA, LLC | $77.84 | 2020-2025 | Ebglyss, Taltz |
| Genzyme Corporation | $63.68 | 2021-2023 | |
| Galderma Laboratories, L.P. | $58.59 | 2025 | Nemluvio |
| Kyowa Kirin, INC. | $40.02 | 2022 | |
| Genentech USA, INC. | $39.70 | 2020-2022 | |
| Organon LLC | $32.99 | 2025 | |
| Pfizer INC. | $27.73 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stemline Therapeutics INC. | $24.47 | 2022 | |
| Almirall LLC | $22.98 | 2025 | Seysara |
| Ucb, INC. | $20.08 | 2025 | Bimzelx |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2024 | |
| Journey Medical Corporation | $19.68 | 2025 | |
| Leo Pharma INC. | $16.86 | 2025 | Anzupgo |
| Paratek Pharmaceuticals, INC. | $15.93 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Truitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.